USFDA completes inspection at Caplin Point's Sterile Injectable site

01 Nov 2016 Evaluate

The United State Food and Drug Administration (USFDA) has completed inspection at Caplin Point Laboratories’ Sterile Injectable site (CP-IV) at Gummidipoondi between October 21 - 28, 2016. There were only two observations.

The company believes these to be of minor in nature and the corrective and preventive actions for these observations will be presented to the USFDA within the next 15 days. The observations made were not related to data integrity.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.



Caplin Point Lab Share Price

1741.25 -35.50 (-2.00%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×